This podcast is based on the recent investor presentation by Ananda Developments PLC, a life sciences company. The podcast focuses on clinical development of CBD-based therapies for complex inflammatory pain conditions and epilepsy trials, which are being funded by the UK government, and its involvement in the development of two CBD-based drugs, MRX2 and MRX2T. These drugs are intended to be licenced for use on the NHS and have the potential for significant commercial success.